-
Taxonomy & unit
-
us-gaap: USD/shares
-
Description
-
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
-
Summary
-
Werewolf Therapeutics, Inc. quarterly/annual Earnings Per Share, Basic history and growth rate from Q1 2020 to Q2 2024.
- Werewolf Therapeutics, Inc. Earnings Per Share, Basic for the quarter ending June 30, 2024 was -0.4 USD/shares, a 186% decline year-over-year.
- Werewolf Therapeutics, Inc. Earnings Per Share, Basic for the twelve months ending June 30, 2024 was -1.36 USD/shares, a 8.8% decline year-over-year.
- Werewolf Therapeutics, Inc. annual Earnings Per Share, Basic for 2023 was -1.05 USD/shares, a 43.5% increase from 2022.
- Werewolf Therapeutics, Inc. annual Earnings Per Share, Basic for 2022 was -1.86 USD/shares, a 83% increase from 2021.
- Werewolf Therapeutics, Inc. annual Earnings Per Share, Basic for 2021 was -10.9 USD/shares, a 61% increase from 2020.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Growth (%)